Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2024-11-29
• Last 15 days FTD volume: A$0.17 M
• Last 3 months FTD volume: A$1.6 M
• Last year FTD volume: A$1.6 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	A$0.14 M	A$0.28 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	A$13.62 M	A$0.10 B	🇺🇸 USA
Ultragenyx RARE	A$0.87 M	A$7.6 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$7.45 M	A$23.02 M	🇺🇸 USA
Thermo Fisher Scientific TMO	A$10.56 M	A$0.28 B	🇺🇸 USA
Esperion Therapeutics ESPR	A$3.65 M	A$17.58 M	🇺🇸 USA
Illumina ILMN	A$27.75 M	A$57.91 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	A$2.22 M	A$10.22 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	A$0.94 M	🇺🇸 USA